Literature DB >> 29302844

Cost-Utility of Access to Care, a National HIV Linkage, Re-engagement and Retention in Care Program.

Catherine Maulsby1, Kriti M Jain2, Brian W Weir2, Blessing Enobun2, Melissa Werner3, Morey Riordan3, David R Holtgrave2.   

Abstract

Linkage to HIV medical care and on-going engagement in HIV medical care are vital for ending the HIV epidemic. However, little is known about the cost-utility of HIV linkage, re-engagement and retention (LRC) in care programs. This paper presents the cost-utility analysis of Access to Care, a national HIV LRC program. Using standard methods from the US Panel on Cost-Effectiveness in Health and Medicine, we calculated the cost-utility ratio. Seven Access to Care programs were cost-effective and two were cost-saving. This study adds to a small but growing body of evidence to support the cost-effectiveness of LRC programs.

Entities:  

Keywords:  Access to Care; Cost–utility; HIV; Retention in HIV care

Mesh：

Substances：

Year:  2018        PMID： 29302844      PMCID： PMC6034976          DOI： 10.1007/s10461-017-2015-z

Source DB:  PubMed          Journal:  AIDS Behav        ISSN： 1090-7165


  27 in total

1.  Health economic evaluations: the special case of end-stage renal disease treatment.

Authors:  Wolfgang C Winkelmayer; Milton C Weinstein; Murray A Mittleman; Robert J Glynn; Joseph S Pliskin
Journal:  Med Decis Making       Date:  2002 Sep-Oct       Impact factor: 2.583

2.  Cost-Utility Analysis of Three U.S. HIV Linkage and Re-engagement in Care Programs from Positive Charge.

Authors:  Kriti M Jain; Rose Zulliger; Cathy Maulsby; Jeeyon Janet Kim; Vignetta Charles; Maura Riordan; David Holtgrave
Journal:  AIDS Behav       Date:  2016-05

3.  Lifetime costs and quality-adjusted life years saved from HIV prevention in the test and treat era.

Authors:  Paul G Farnham; David R Holtgrave; Chaitra Gopalappa; Angela B Hutchinson; Stephanie L Sansom
Journal:  J Acquir Immune Defic Syndr       Date:  2013-10-01       Impact factor: 3.731

4.  Cost-effectiveness of HIV interventions: from cohort studies and clinical trials to policy.

Authors:  Rochelle P Walensky
Journal:  Top HIV Med       Date:  2009 Sep-Oct

Review 5.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

Authors:  M C Weinstein; J E Siegel; M R Gold; M S Kamlet; L B Russell
Journal:  JAMA       Date:  1996-10-16       Impact factor: 56.272

6.  Cost and cost threshold analyses for 12 innovative US HIV linkage and retention in care programs.

Authors:  Kriti M Jain; Catherine Maulsby; Meredith Brantley; Jeeyon Janet Kim; Rose Zulliger; Maura Riordan; Vignetta Charles; David R Holtgrave
Journal:  AIDS Care       Date:  2016-03-28

7.  Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.

Authors:  Bohdan Nosyk; Jeong E Min; Viviane D Lima; Robert S Hogg; Julio S G Montaner
Journal:  Lancet HIV       Date:  2015-07-16       Impact factor: 12.767

Review 8.  The state of engagement in HIV care in the United States: from cascade to continuum to control.

Authors:  Michael J Mugavero; K Rivet Amico; Tim Horn; Melanie A Thompson
Journal:  Clin Infect Dis       Date:  2013-06-23       Impact factor: 9.079

9.  The Epidemiologic and Economic Impact of Improving HIV Testing, Linkage, and Retention in Care in the United States.

Authors:  Maunank Shah; Kathryn Risher; Stephen A Berry; David W Dowdy
Journal:  Clin Infect Dis       Date:  2015-09-11       Impact factor: 9.079

10.  Cost effectiveness of the National HIV/AIDS Strategy goal of increasing linkage to care for HIV-infected persons.

Authors:  Chaitra Gopalappa; Paul G Farnham; Angela B Hutchinson; Stephanie L Sansom
Journal:  J Acquir Immune Defic Syndr       Date:  2012-09-01       Impact factor: 3.731
View more
  5 in total

Review 1.  Cost-Effectiveness of HIV Retention and Re-engagement Interventions in High-Income Countries: A Systematic Literature Review.

Authors:  Margo M Wheatley; Gregory S Knowlton; Mary Butler; Eva A Enns
Journal:  AIDS Behav       Date:  2022-01-25

2.  Cumulative Effects of Stigma Experiences on Retention in HIV Care Among Men and Women in the Rural Southeastern United States.

Authors:  Seth C Kalichman; Harold Katner; Ellen Banas; Marnie Hill; Moira O Kalichman
Journal:  AIDS Patient Care STDS       Date:  2020-11       Impact factor: 5.078

3.  Outcomes and costs of publicly funded patient navigation interventions to enhance HIV care continuum outcomes in the United States: A before-and-after study.

Authors:  Starley B Shade; Valerie B Kirby; Sally Stephens; Lissa Moran; Edwin D Charlebois; Jessica Xavier; Adan Cajina; Wayne T Steward; Janet J Myers
Journal:  PLoS Med       Date:  2021-05-13       Impact factor: 11.069

4.  The Cost Effectiveness of Mental Health Treatment in the Lifetime of Older Adults with HIV in New York City: A Markov Approach.

Authors:  Juan J DelaCruz; Mark Brennan-Ing; Andreas Kakolyris; Omar Martinez
Journal:  Pharmacoecon Open       Date:  2020-11-09

Review 5.  The Cost-Effectiveness of HIV/STI Prevention in High-Income Countries with Concentrated Epidemic Settings: A Scoping Review.

Authors:  Palmo Brunner; Karma Brunner; Daniel Kübler
Journal:  AIDS Behav       Date:  2022-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.